Finance Home - My Yahoo - Yahoo! - Help

Thursday, December 3, 2009, 1:20AM ET - U.S. Markets open in 8 hours and 10 minutes. Dow  0.18% Nasdaq  0.42%

Spherix Inc. (SPEX)

On Dec 2: 1.38   0.02 (1.43%)

MORE ON SPEX

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Competitors Get Competitors for:
DIRECT COMPETITOR COMPARISON   SPEX LLY NVO SNY Industry Market Cap: 19.86M 43.10B 41.35B 103.79B 80.33M Employ­ees: 9 40,500 28,497 98,213 474 Qtrly Rev Growth (yoy): 23.00% 6.80% 11.30% 8.50% 13.50% Revenue (ttm): 1.38M 21.11B 10.19B N/A 141.20M Gross Margin (ttm): 65.73% 82.33% 79.57% 75.20% 47.15% EBITDA (ttm): -7.10M 7.74B 3.52B N/A 8.84M Oper Margins (ttm): -519.42% 30.97% 29.92% N/A 6.81% Net Income (ttm): -6.54M -216.00M 2.17B N/A N/A EPS (ttm): -0.352 -0.197 3.56 N/A N/A P/E (ttm): N/A N/A 19.47 N/A 23.59 PEG (5 yr expected): N/A 4.01 1.19 2.59 1.41 P/S (ttm): 14.56 2.02 4.04 N/A 1.79 LLY = Eli Lilly & Co. NVO = Novo Nordisk A/S SNY = Sanofi-Aventis Industry = Medical Laboratories & Research NEWS ON DIRECT COMPETITORS   • SNY Tough Sell: Sanofi Hands Out 750 Pink Slips to Sales Force Wed 4:14pm - at The Wall Street Journal Online • LLY Roche Makes Strides in Race Against Merck Wed 12:25pm - at Minyanville.com • LLY Medtronic names Coyle head of cardiology Wed 12:05pm - at bizjournals.com • LLY Another Approval for LLY's Cymbalta Wed 11:06am - Zacks.com • SNY H1N1: What It Means for Pharma Wed 9:47am - at Seeking Alpha • NVO InPlay: Novo-Nordisk A/S announces that the FDA approves 10 mcg dose of Vagifem for the treatment of atrophic vaginitis due to menopause Wed 9:03am - Briefing.com • NVO FDA Approves 10 mcg Dose of Vagifem(R) for the Treatment of Atrophic Vaginitis Due to Menopause Wed 9:00am - PR Newswire • SNY Immunogen's Busy Month, Part II Wed 7:46am - at Seeking Alpha • SNY The Man Who Will Run NBC Wed 6:00am - at Forbes.com • SNY UBS ups Europe pharma rating to overweight Wed 3:34am - at MarketWatch • LLY 3 Stocks With Single-Digit P/Es Tue, Dec 1 - at SmartMoney.com • LLY Bonds: Out. Stocks: Out. What's Left? Tue, Dec 1 - at Motley Fool • LLY Lilly Releases Latest 'Value of Medicine' Resource Guide About Key Issues Facing the Pharmaceutical Industry Tue, Dec 1 - PR Newswire • SNY Better Buy: Pfizer or Teva Pharmaceutical? Tue, Dec 1 - at Motley Fool • SNY A Defensive Tone from Cramer Tue, Dec 1 - at Seeking Alpha • SNY 5-Star Stocks Poised to Pop: Abbott Labs Tue, Dec 1 - at Motley Fool • NVO Increase In Patent Protection For Biologics Creates Significant Upside For Drug Development Enterprise Valuations Sat, Nov 28 - Wall Street Transcript • NVO Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows Fri, Nov 27 - PR Newswire • NVO The Complete List of Danish ADR Stocks Fri, Nov 20 - at Seeking Alpha • NVO Doctors Cite Time, Low Reimbursement As Barriers To Providing Comprehensive Diabetes Care, Survey Results Show Thu, Nov 19 - PR Newswire All Headlines for these symbols... Need more? Get unbiased, in-depth information on public and private companies worldwide from Hoover's Online.
Add to Portfolio     Set Alert     Email to a Friend Get Competitors for Another Symbol: Symbol Lookup • Stock Screener • Sector Analysis